Expanding and Personalizing Treatment Options for Alcohol Use Disorders Including Pharmacogenomics (R01)

Post Date

June 16th 2010

Application Due Date

September 7th 2011

Funding Opportunity Number

PAS-10-215

CFDA Number(s)

93.273

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Number of Awards

4

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $2000000

• Award Range:

  $None - $None

Grant Description

Purpose. Under this Funding Opportunity Announcement (FOA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA) requests research project grants (R01) to study how genetic variation affects responses to medications for the treatment of Alcohol Use Disorders (AUD). Both human and animal studies are encouraged to determine the full range of genetic variation affecting both pharmacodynamic and pharmacokinetic parameters resulting in altered drug efficacy and toxicity. Mechanistic studies using animal models and/or in vitro/ex vivo preparations are also encouraged. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. NIAAA has available $2 million in total cost for fiscal year 2011 for this announcement and expects that two to four awards will be made.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAS-10-215.html